PREDICTIVE TECHNOLOGY GROUP, INC. (17)

Browse by Contract Category

Contracts

Operations Agreement dated January 31, 2022 (Filed With SEC on February 4, 2022)
Asset Purchase Agreement dated January 18, 2021 (Filed With SEC on January 24, 2022)
Amendment and Termination Agreement (Filed With SEC on January 19, 2021)
Consulting Agreement, dated September 25, 2020, by and between ProPhase Labs, Inc. and Predictive Labs, Inc (Filed With SEC on September 30, 2020)
Acquisition Agreement (Filed With SEC on January 6, 2022)
Exclusive Distribution Services Agreement, dated April 1, 2020, by and between Predictive Laboratories, Inc. and Wellgistics, LLC. (Portions of this exhibit have been omitted in... (Filed With SEC on April 7, 2020)
Revolving Loan Agreement by and between the Company and The Qyu Holdings, Inc. effective September 25, 2019 (Filed With SEC on September 30, 2019)
Form of Promissory Notes by and between the Company and accredited investors, effective between June 28, 2019 and September 30, 2019 (Filed With SEC on September 30, 2019)
Amendment No. 3 to the Second Amended and Restated Subscription Agreement by and between the Company and Juneau Biosciences, LLC, effective September 25, 2019 (Filed With SEC on September 30, 2019)
FIRST AMENDED AND RESTATED SECURITIES PURCHASE AGREEMENT (Filed With SEC on March 25, 2019)
Amendment No. 1 to the Securities Purchase Agreement, by and between the Company and Taueret Laboratories, LLC and its equity holders, effective February 11, 2019 (Filed With SEC on February 14, 2019)
Amendment No. 1 to the Amended and Restated Subscription Agreement between the Company and Juneau Biosciences, LLC, effective January 1, 2019 (Filed With SEC on February 14, 2019)
Employment Agreement with Eric Olson (Filed With SEC on February 14, 2019)
Employment Agreement with Simon Brewer (Filed With SEC on February 14, 2019)
Employment Agreement with Paul Evans (Filed With SEC on February 14, 2019)
Employment Agreement with Bradley Robinson (Filed With SEC on February 14, 2019)
Securities Purchase Agreement, by and between the Company and Taueret Laboratories, LLC and its equity holders, effective January 1, 2019 (Filed With SEC on February 14, 2019)